Cite
HARVARD Citation
Genovese, M. et al. (2014). Efficacy and safety of olokizumab in patients with rheumatoid arthritis with an inadequate response to TNF inhibitor therapy: outcomes of a randomised Phase IIb study. Annals of the rheumatic diseases. 73 (9), pp. 1607-1615. [Online].